Prognostic Determinants in Patients with Secondary Tricuspid Regurgitation Classified by Right Ventricular Systolic Function
RVFAC serves as an effective prognostic marker in severe STR patients, with additional assessment of TAPSE and morphological parameters enhancing risk stratification. These findings underscore the importance of comprehensive right heart evaluation in managing STR-associated HF, facilitating tailored therapeutic strategies, and improving patient outcomes.
Authors
- Yui Kuroki
- Eiji Toyosaki
- Toshiro Shinke (ORCID: https://orcid.org/0000-0001-7349-7538)
- Yasuhide Mochizuki (ORCID: https://orcid.org/0000-0003-0485-7012)
- Hiroto Fukuoka
- Mamiko Yamada (ORCID: https://orcid.org/0000-0002-4039-8899)
- Rumi Hachiya (ORCID: https://orcid.org/0000-0001-8412-3494)
- Yukiko Endo
- Yumi Yamamoto (ORCID: https://orcid.org/0000-0002-5376-5096)
- Keita Oshima
- E Kunimoto
- Sakiko Gohbara
- Saaya Ichikawa-Ogura
- Ayaka Oda
Institutions
- SHOWA Medical University (JP)
- SHOWA Medical University Hospital (JP)
Publication Details
- Journal
- Cardiology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1159/000549540
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00